Alcon recently announced it has received approval from the U.S. FDA for its AcrySof® IQ ReSTOR® +2.5 Multifocal Toric intraocular lens (IOL) with ACTIVEFOCUS™ optical design for patients undergoing cataract surgery that choose to address their astigmatism and presbyopia at the same time.
The ACTIVEFOCUS toric IOL is reportedly the only multifocal toric IOL in which the central portion is 100 percent dedicated to distance vision. The unique design of the lens allows it to deliver both crisp, clear distance vision and a range of vision for patients who desire less dependence on glasses. And according to Alcon, the AcrySof IQ toric IOL platform was 2.5 times less likely to rotate than the leading competitor lens in a retrospective study of IOL orientation data.
Alcon reportedly plans to commercialize the ACTIVEFOCUS toric IOL in the US beginning in mid-2017.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.